Lipid nanoparticles that deliver mRNA to T cells hold promise against autoimmune diseases
Date | 14th, Nov 2023 |
---|---|
Source | Phys.org - Scientific News Websites |
DESCRIPTION
Autoimmune disorders are among the most prevalent chronic diseases across the globe. Emerging treatments for autoimmune disorders focus on "adoptive cell therapies," or those using cells from a patient's own body to achieve immunosuppression. These therapeutic cells are recognized by the patient's body as "self," therefore limiting side effects, and are specifically engineered to localize the intended therapeutic effect.